From: Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
 | BRCA 1/2 mut | BRCA1/2 wt |
---|---|---|
nâ=â19 | nâ=â81 | |
Age at diagnosis, median (range), years | 54 (39â63) | 55 (33â81) |
Time between diagnosis and inclusion (months) | 23.33â±â14.53 | 19.83â±â13.52 |
Histology, n (%) | ||
âSerous | 18 (94.7) | 66 (81.5) |
âNon-serous | 1 (5.3) | 15 (18.5) |
Clinical Stage, n (%) | ||
âI/II | 0 (0) | 21 (25.9) |
âIII/IV | 19 (100) | 59 (72.8) |
âMissing | 0 (0) | 1 (1.2) |
Region of origin, n (%) | ||
âSoutheast | 9 (47.4) | 48 (59.3) |
âNortheast | 7 (36.8) | 21 (25.9) |
âSouth | 2 (10.5) | 8 (9.9) |
âNorth | 1 (5.3) | 1 (1.2) |
âAbroad | 0 (0) | 2 (2.4) |
âMissing | 0 (0) | 1 (1.2) |
Ancestry until 3rd degree, n (%) | ||
âBrazilian only | 7 (36.8) | 31 (38.3) |
âEuropean only | 2 (10.5) | 12 (14.8) |
âJapanese only | 1 (5.3) | 4 (4.9) |
âAsian only | 0 (0) | 1 (1.2) |
âBrazilian and European | 5 (26.3) | 16 (19.8) |
âBrazilian and Indigenous | 2 (10.5) | 1 (1.2) |
âIndigenous and European | 0 (0) | 1 (1.2) |
âIndigenous and Brazilian and European | 2 (10.5) | 1 (1.2) |
âBrazilian and African | 0 (0) | 2 (2.5) |
âBrazilian and African and European | 0 (0) | 1 (1.2) |
âBrazilian and Japanese | 0 (0) | 2 (2.5) |
âUnknown | 0 (0) | 8 (9.9) |
âMissing | 0 (0) | 1 (1.2) |
Family history for breast and/or ovarian cancer | ||
âPositive (first and/or second-degree relatives) | 11 (57.9) | 20 (24.7) |
âNegative | 5 (26.3) | 32 (39.5) |
âNot Completely Known/Unknown | 3(15.8) | 29 (35.8) |